Atria Investments’s VanEck CLO ETF CLOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.54M Buy
142,469
+113,660
+395% +$6M 0.08% 285
2026
Q1
$1.52M Buy
28,809
+1,401
+5% +$73.9K 0.02% 834
2025
Q4
$1.45M Sell
27,408
-4,550
-14% -$241K 0.02% 881
2025
Q3
$1.7M Sell
31,958
-25,877
-45% -$1.37M 0.02% 788
2025
Q2
$3.06M Sell
57,835
-12,595
-18% -$663K 0.04% 556
2025
Q1
$3.72M Buy
70,430
+38,421
+120% +$2.03M 0.05% 458
2024
Q4
$1.69M Buy
32,009
+27,716
+646% +$1.47M 0.02% 751
2024
Q3
$228K Sell
4,293
-151
-3% -$7.98K ﹤0.01% 1763
2024
Q2
$235K Buy
+4,444
New +$235K ﹤0.01% 1729

Other funds holding CLOI

Atria Investments's CLOI Position: Q2 2026 in Review

Atria Investments increased its VanEck CLO ETF (CLOI) stake by 395% in Q2 2026, buying an estimated $6M and bringing the position to 142,469 shares worth $7.54M. The position accounts for 0.08% of the portfolio, ranked #285.

Atria Investments first reported a position in CLOI in Q2 2024 and has held it in 9 quarters since. 197 funds tracked by Wall St. Rank hold CLOI as of Q2 2026.

  • Atria Investments held 142,469 shares of VanEck CLO ETF worth $7.54M as of Q2 2026.
  • Atria Investments bought 113,660 VanEck CLO ETF shares in Q2 2026, an estimated $6M.
  • VanEck CLO ETF made up 0.08% of Atria Investments's portfolio in Q2 2026, its #285 holding.
  • Atria Investments first reported a position in VanEck CLO ETF in Q2 2024 and has held it in 9 quarters since.
  • 197 funds tracked by Wall St. Rank held VanEck CLO ETF as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.